0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Observation |

Sycosis Vaccinatum, a Type of Vaccinia Folliculitis FREE

Mark A. Braswell, BS1; Matthew W. Morrissey, MD2; Simon A. Ritchie, MD2; Robert L. Reddick, MD3; Todd T. Kobayashi, MD2
[+] Author Affiliations
1Kansas City University of Medicine and Biosciences, Kansas City, Missouri
2San Antonio Uniformed Services Health Education Consortium, San Antonio, Texas
3Department of Pathology, University of Texas Health Science Center at San Antonio, San Antonio
JAMA Dermatol. 2015;151(7):799-801. doi:10.1001/jamadermatol.2015.0380.
Text Size: A A A
Published online

We present a case of vaccinia folliculitis that we term sycosis vaccinatum to correctly identify its etiology and scope of infection.

REPORT OF A CASE

A healthy, immunocompetent 30-year-old man undergoing basic military training presented with a 4-day history of a progressive vesiculopustular eruption of the anterior neck and chin. The patient denied symptoms of pruritus, burning, or fever at time of presentation. This patient had not received the smallpox vaccination, but he had engaged in simulated unarmed combat with individuals who had recently been vaccinated. Medical history was noncontributory, and the patient was not taking any medications.

Examination revealed more than 2 dozen monomorphic, broad-based folliculocentric pustules with central umbilication, overlying serum crust, and surrounding erythema and edema of the anterior neck, chin, and inferior cheeks (Figure 1). The patient was admitted to the hospital owing to the extensive disease burden and to protect his daughter, who had atopic dermatitis (a risk factor for developing disseminated disease). The patient’s hospital course was notable for continued development of new lesions, fevers to 39°C, progressive edema of the face, and anterior cervical lymphadenopathy. The continued evolution of his disease required vaccinia immune globulin (VIG) therapy.

Place holder to copy figure label and caption
Figure 1.
Sycosis Vaccinatum, Clinical Findings

Vesiculopustules with central umbilication in the beard area at time of presentation.

Graphic Jump Location

A punch biopsy taken early in his hospital course demonstrated classic viral changes to the epidermis consisting of ballooning degeneration of keratinocytes with intracytoplasmic inclusions (Guarnieri bodies) and a brisk lymphocytic and neutrophilic infiltrate (Figure 2A and B). The presence of vaccinia virus was confirmed by polymerase chain reaction (PCR). Electron microscopy demonstrated viral particles typical of vaccinia present within the Guarnieri bodies (Figure 2C and D). Two weeks after initial presentation, pink depressed scars were present on the chin and jawline.

Place holder to copy figure label and caption
Figure 2.
Sycosis Vaccinatum, Histopathologic Findings From Lesional Skin of the Right Cheek

A and B, Hematoxylin-eosin–stained specimens. A, Epidermal necrosis and prominent intraepidermal edema with ballooning degeneration (original magnification ×40). B, Early ballooning degeneration, necrotic keratinocytes, neutrophilic infiltrate, and Guarnieri bodies (arrowhead) within the pale staining cytoplasm of a ballooned keratinocyte (original magnification ×600). C and D, Electron microscopic images of specimens. C, Clusters of viral particles (arrowhead) present within necrotic keratinocytes (original magnification ×5000). D, A variety of morphologic forms were present; some were electron dense and had a somewhat homogeneous appearance (single arrowhead); others had a partial clearing of the internal portion of the viral particle (double arrowhead); both forms were bordered by a double limiting membrane and were covered by a dense layer of amorphous material (original magnification ×150 000).

Graphic Jump Location

DISCUSSION

We propose the term sycosis vaccinatum to describe the autoinoculation of vaccinia in the beard area with resulting viral folliculitis seen in the present case. To our knowledge, this reaction has not been discussed in the literature or reported to the vaccine adverse event reporting system (VAERS). In contrast to the term vaccinia folliculitis, sycosis vaccinatum describes the diagnosis and clinical presentation and avoids confusion with postvaccinial nonviral folliculitis (PVNVF).1,2

The course of sycosis vaccinatum parallels the progression at a primary vaccination site from vesiculopustule to crusted papule and ultimately to healing with a depressed scar. The timing of sycosis vaccinatum evolution is 7 to 10 days following vaccination, which is similar to that of PVNVF. However, sycosis vaccinatum is a localized form of autoinoculation, whereas PVNVF is a poorly understood idiosyncratic inflammatory or hypersensitivity response to vaccination.1,2

Findings of PCR, viral cultures, electron microscopy, immunohistochemical (IHC) analysis, and immunofluorescence (IF) studies are negative for the vaccinia virus in PVNVF but positive in sycosis vaccinatum.1,2 We confirmed sycosis vaccinatum by PCR, following the guidelines of the Centers for Disease Control and Prevention (CDC) for confirming a case of inadvertent autoinnoculation.3 Histopathologic analysis in sycosis vaccinatum shows ballooning degeneration of keratinocytes within the epidermis with intracytoplasmic inclusions called Guarnieri bodies.2 An acute inflammatory cell infiltrate composed of neutrophils and lymphocytes extending into the epidermis is also characteristic. Use of IHC analysis and IF studies can also identify the vaccinia virus.3 The preferred diagnostic test is PCR because it is more sensitive than culture and does not require expertise in processing or interpreting electron microscopic specimens.

Treatment for sycosis vaccinatum is primarily supportive, involving local wound care and measures taken to prevent further inoculation (cessation of shaving, covering of the wounds, and avoidance of contact with other people). Sycosis vaccinatum requires VIG therapy if systemic symptoms are present, and any VIG use should follow CDC recommendations for systemically ill patients with generalized vaccinia, progressive vaccinia, or eczema vaccinatum to reduce morbidity and mortality.3

ARTICLE INFORMATION

Corresponding Author: Todd T. Kobayashi, MD, Dermatology Residency Program, San Antonio Uniformed Services Health Education Consortium, 2200 Bergquist Dr, 59th Medical Wing/SG07D, Ste 1, JBSA Lackland Air Force Base, TX 78236-9908 (todd.kobayashi@us.af.mil).

Published Online: April 22, 2015. doi:10.1001/jamadermatol.2015.0380.

Conflict of Interest Disclosures: None reported.

REFERENCES

Bunick  CG, Mariwalla  K, Ibrahim  O, Modi  B, Imaeda  S, McNiff  JM.  Expanding the histologic findings in smallpox-related post-vaccinial non-viral folliculitis. J Cutan Pathol. 2013;40(3):305-309.
PubMed
Talbot  TR, Bredenberg  HK, Smith  M, LaFleur  BJ, Boyd  A, Edwards  KM.  Focal and generalized folliculitis following smallpox vaccination among vaccinia-naive recipients. JAMA. 2003;289(24):3290-3294.
PubMed   |  Link to Article
Casey  C, Vellozzi  C, Mootrey  GT,  et al; Vaccinia Case Definition Development Working Group; Advisory Committee on Immunization Practices-Armed Forces Epidemiological Board Smallpox Vaccine Safety Working Group.  Surveillance guidelines for smallpox vaccine (vaccinia) adverse reactions. MMWR Recomm Rep. 2006;55(RR-1):1-16.
PubMed

Figures

Place holder to copy figure label and caption
Figure 1.
Sycosis Vaccinatum, Clinical Findings

Vesiculopustules with central umbilication in the beard area at time of presentation.

Graphic Jump Location
Place holder to copy figure label and caption
Figure 2.
Sycosis Vaccinatum, Histopathologic Findings From Lesional Skin of the Right Cheek

A and B, Hematoxylin-eosin–stained specimens. A, Epidermal necrosis and prominent intraepidermal edema with ballooning degeneration (original magnification ×40). B, Early ballooning degeneration, necrotic keratinocytes, neutrophilic infiltrate, and Guarnieri bodies (arrowhead) within the pale staining cytoplasm of a ballooned keratinocyte (original magnification ×600). C and D, Electron microscopic images of specimens. C, Clusters of viral particles (arrowhead) present within necrotic keratinocytes (original magnification ×5000). D, A variety of morphologic forms were present; some were electron dense and had a somewhat homogeneous appearance (single arrowhead); others had a partial clearing of the internal portion of the viral particle (double arrowhead); both forms were bordered by a double limiting membrane and were covered by a dense layer of amorphous material (original magnification ×150 000).

Graphic Jump Location

Tables

References

Bunick  CG, Mariwalla  K, Ibrahim  O, Modi  B, Imaeda  S, McNiff  JM.  Expanding the histologic findings in smallpox-related post-vaccinial non-viral folliculitis. J Cutan Pathol. 2013;40(3):305-309.
PubMed
Talbot  TR, Bredenberg  HK, Smith  M, LaFleur  BJ, Boyd  A, Edwards  KM.  Focal and generalized folliculitis following smallpox vaccination among vaccinia-naive recipients. JAMA. 2003;289(24):3290-3294.
PubMed   |  Link to Article
Casey  C, Vellozzi  C, Mootrey  GT,  et al; Vaccinia Case Definition Development Working Group; Advisory Committee on Immunization Practices-Armed Forces Epidemiological Board Smallpox Vaccine Safety Working Group.  Surveillance guidelines for smallpox vaccine (vaccinia) adverse reactions. MMWR Recomm Rep. 2006;55(RR-1):1-16.
PubMed

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

550 Views
0 Citations
×

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
Jobs